Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00161382 · ClinicalTrials.gov registry record · NA

Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
3,007
Enrollment target

NCT00161382: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT00161382 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3,007 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00161382, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
3,007 participants
Enrollment target

Study Summary

This study will develop and evaluate a school-based HIV, STD, and pregnancy prevention program for 7th and 8th grade middle school students.

Primary Outcome

The effect of the intervention on delayed sexual initiation at the 9th-grade follow-up for those students who reported no lifetime sexual activity at baseline was assessed as the primary outcome. The primary hypothesis tested was that the intervention would decrease the number of adolescents who initiated sexual activity by the ninth grade relative to those in the comparison schools. Sexual activity was defined as participation in vaginal, oral, or anal sex. Sexual activity questions were define

Interventions

  • BEHAVIORAL HIV, STD, and pregnancy prevention curriculum
  • BEHAVIORAL Standard sexual education curriculum

Trial Details

FieldValue
Enrollment Target 3,007 participants
Start Date 2002-09
Est. Completion 2008-07
Phase NA

What the finished NCT00161382 record still lists

NCT00161382 is an interventional study that assigns participants to a tested intervention. Its 3,007 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).

The record links to 0 conditions, and to 2 interventions - of which HIV, STD, and pregnancy prevention curriculum is the first listed.

NCT00161382 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00161382 about?

NCT00161382 is a clinical study titled "Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students". This study will develop and evaluate a school-based HIV, STD, and pregnancy prevention program for 7th and 8th grade middle school students.

What is the current status of trial NCT00161382?

This trial is currently completed. It is a NA study. The enrollment target is 3,007 participants. The study started on 2002-09. Estimated completion is 2008-07.

What interventions are being tested in trial NCT00161382?

The interventions under investigation include: HIV, STD, and pregnancy prevention curriculum (BEHAVIORAL), Standard sexual education curriculum (BEHAVIORAL).

Who is sponsoring clinical trial NCT00161382?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00161382's enrollment target sits among peer trials

3,007 40th of 2000 higher than 1,961 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00161382, the US trial registry maintained by the National Library of Medicine. NCT00161382 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.